Joint RFPs: Strengthening Health & Disease Modeling for Public Health Decision Making in Africa

Deadline: 23-Oct-23

The Bill & Melinda Gates Foundation (BMGF) and Wellcome are seeking proposals for innovative, high-quality modeling projects that will address specific research questions whilst:

• increasing connectedness between African modeling institutes.
• growing the African modeling ecosystem.
• accelerating the translation of modeling outputs into meaningful policy and programmatic impact.

Objectives

• They are looking for projects with a duration of 3-5 years that will achieve the following objectives:
  • Advance scientific understanding of key public health priority areas and leverage modeling outputs to inform decision-making by local, regional, or continental health officials and agencies.
  • Develop, implement, and/or improve tools, processes and methods that enable the use of modeling to inform public health decision-making.
  • Strengthen connections between African modeling units, data partners (e.g. data scientists/collectors) and policy- and decision-making officials and agencies through collaborative projects. Such collaboration should lead to programmatic impact, with co-creation of the analytical questions, analysis plans, and communication of outputs.
  • Design and execute South-South collaborative activities to support knowledge exchange, cultivate partnerships between modeling units, and promote the use of modeling within health systems.
  • Use community standards for open science, including FAIR (findable, accessible, interoperable, reusable) principles where possible, thereby contributing to the development of trustworthy data science to promote collaboration within funded projects and beyond.

Scope and Scale of Proposed Work

• Wellcome and Bill & Melinda Gates Foundation (BMGF) will collaborate to achieve the overall program objectives, but successful proposals will receive awards either through Wellcome or BMGF depending on the scope and scale of the proposed work. At the application stage, you will be required to indicate if your proposal is being made to Wellcome (Option A) or BMGF (Option B).
  • Option A – Wellcome-funded
    • Wellcome anticipates funding proposals of up to £3,000,000 GBP for each award for a duration of 3-5 years. Proposals must demonstrate that at least 70% of the funding is going to low-and middle-income country (LMIC) institutions with at least 50% of the funding going to African institutions. Proposals can include institutions in high-income countries (HICs). However, no more than 30% of the project budget can go to HIC institutions.
    • Wellcome’s focus is on vector-borne diseases which cause significant morbidity, with a high burden in Africa. This includes a range of diseases spread by vectors (or intermediate hosts), such as mosquitoes and snails. The distribution of the vectors that spread these diseases is sensitive to environmental change. For example, climate change is leading to warmer temperatures, increasing the expansion and geographic spread of mosquitoes and associated diseases to wider areas.
    • Thematic areas of focus
      • Proposals must focus on one or more of the following diseases: Chikungunya, dengue, yellow fever, zika, malaria and schistosomiasis. Proposals must address one or more of the following:
        • Environmental change: Modeling to understand the effect of i) direct climate (e.g., temperature, rainfall, short/long-term climate change) and/or ii) indirect environmental (e.g., population movement, landscape change) factors on the spread and burden of the focus diseases (e.g., vector spread, behavior, ability to transmit disease), and implications for control.
        • Control interventions: Modeling to i) understand optimal use of existing and novel interventions (including combinations of interventions and assessment of resistance to interventions where relevant), and ii) identify barriers to implementation and uptake of interventions for the focus diseases.
  • Option B – BMGF-funded
    • BMGF anticipates funding proposals up to $1,000,000 USD for each award for a duration of 3- 5 years. Proposals must demonstrate that at least 80% of the funding is going to African institutions. Proposals can include institutions from other regions. However, no more than 20% of the project budget can go to institutions outside of Africa.
    • Proposals to BMGF must address one or more of the thematic areas of focus below and may include additional topics related to understanding of the burden of disease that are aligned with local priorities. All proposals are encouraged to explore how artificial intelligence (in particular, large language models) can be leveraged to advance data management, modeling methods, and communication of project findings. Proposals are also encouraged to consider how their approach will increase knowledge and understanding of gender barriers in modeling OR display how their methodologies would alleviate a known gender gap/issue with respect to the public health theme selected.
    • Thematic areas of focus
      • Proposals should address one or more of the following thematic areas.
        • HIV, including exploration of multi-pathogen or multi-systems questions such as integration of HIV with sexually transmitted diseases, family planning, or non-communicable diseases.
        • Neglected tropical diseases (human African trypanosomiasis, visceral leishmaniasis, Guinea worm, lymphatic filariasis, onchocerciasis, schistosomiasis, soil-transmitted helminth, trachoma), addressing questions of how to target interventions, evaluate new and potential interventions, and assess risk of resurgence once an intervention is stopped.
        • Malaria and climate: Exploring the intersection between climate change and malaria vector ecology and/or malaria epidemiology; this may also include modeling the expected impact of climate change on malaria intervention efficacy.
        • Malaria control interventions: Understanding the optimal sub-national deployment of existing malaria control interventions, defining the ideal characteristics and deployment of novel products and product classes, assessing the cost-effectiveness of existing interventions in the content of a national strategic plan.
        • Enteric and diarrheal diseases (diarrheal disease and etiologies, typhoid and other invasive Salmonellosis, and Hepatitis A and/or E): Understanding of disease transmission, local/regional/global burden of disease, pathogen burden forecasting, public health and economic impact of vaccination, integration of vaccination with other prevention/control strategies, or vaccine targeting for optimal impact.
        • Primary health care (PHC) service delivery and management: Advancing modeling approaches to optimize health structures and inputs (financing, infrastructure, supplies, workforce, information systems) for improved service delivery that meets population health needs and leads to improved PHC system outcomes and impacts. Leverage available data to drive modeling approaches that support national, subnational, and/or facility decision-making to optimize available health inputs for equitable, high-quality PHC service readiness and delivery. This theme may be either a primary focus or conducted as a component of another thematic area, such as routine immunization, HIV, or malaria PHC services.
        • Maternal and newborn health: Quantifying the epidemiology of conditions and intergenerational risk factors linking maternal and fetal/newborn health, assessing the potential impact of existing and emerging interventions, and exploring interactions within and across the health system at critical points of care (e.g., antenatal care, in-facility delivery, newborn intensive care units).
        • Nutrition: Use of modeling to support decision-makers to set priorities for the most cost-effective means of improving micronutrient status. For example, estimating the contribution of vitamins and minerals from fortified foods (staples and condiments) towards improved nutrient intake.
        • Immunization program planning and policy: Scope can include the full expanded program on immunization (EPI), however strongest consideration will be given to those focused on measles, HPV, and/or zero-dose communities (those fully unreached by routine immunization).
        • The impact of climate and environmental change on population movement and impact on transmission/burden of diseases, such as HIV, TB, malaria, and enteric and diarrheal diseases, and planning of primary health care and immunization services.

Eligibility Criteria

• The lead applicant and their institutions must be based in Africa. They particularly encourage applications from women-led organizations or projects led by women.
• Proposals must follow the guidance for Option A and Option B on budget allocation for African institutions versus other regions.
• This RFP is open to researchers at any career stage. Applications led by early- and mid-career investigators are encouraged.
• Applicants must have the experience needed to drive and lead a research program addressing the thematic area(s) of interest.
• Researchers may participate as co-applicants or collaborators on multiple proposals but may submit only one application as a lead applicant to this funding call. If researchers are co-applicants or collaborators on multiple proposals, they must be able to demonstrate that they can dedicate enough time and resources to all projects if all the projects they are involved in are funded.
• Additionally, for projects funded through Wellcome only:
  • Lead applicants must have a permanent, open-ended, or long-term rolling contract for the duration of the award.
  • Lead applicants and co-applicants must be able to contribute at least 20% of their time to this project.
  • Lead applicants must be based at an eligible administering organization that can sign up to the grant conditions and grant funding policies.
  • There is a limit on the number of active Wellcome awards an individual can hold at one time (based on career stage). Please refer to guidance on this.
  • Proposals are limited to 8 co-applicants. There is no limit to the number of collaborators an application can have but the added value must be clear. There is no minimum time commitment for collaborators.
  • Co-applicants must have a guarantee of space from their host institution for the duration of their commitment to the award, but do not need to have a permanent, open-ended, or long-term rolling contract at their administering institution.
  • Co-applicants cannot be based in mainland China.
  • Applicants cannot apply if intending to carry out activities that involve the transfer of grant funds into mainland China.

Ineligibility Criteria

• They will not consider funding for proposals that:
  • Do not directly address the core objectives and at least one of the thematic areas of focus outlined by each funding organization.
  • Are not led by Lead Applicants (and their institutions) based in Africa.
  • Have not engaged local and/or regional decision-/policy-makers or do not include a plan to do so.
  • Do not demonstrate a pathway to decision-making that results in sustainable impact on public health.
  • Do not demonstrate a clear commitment to open science and making their findings, processes, and/or tools accessible and reusable, where possible.
  • Are focused primarily on educational or training programs.
  • Are submitted by teams not committed to collaboration with other projects funded through this RFP.
  • Are focused on conducting primary data collection alone – projects must include a substantive modeling component.
  • Aim to conduct clinical trials or randomized control trials.
  • Cannot be accomplished within a 5-year project duration.

For more information, visit Bill & Melinda Gates Foundation.